Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in
threatened abortion. Half of participants will receive oral dydrogesterone, while the other
half will receive oral placebo.